Logo image of SDGR

SCHRODINGER INC (SDGR) Stock Fundamental Analysis

NASDAQ:SDGR - Nasdaq - US80810D1037 - Common Stock - Currency: USD

20.645  +0.52 (+2.61%)

Fundamental Rating

4

Taking everything into account, SDGR scores 4 out of 10 in our fundamental rating. SDGR was compared to 36 industry peers in the Health Care Technology industry. While SDGR has a great health rating, there are worries on its profitability. SDGR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SDGR had negative earnings in the past year.
In the past year SDGR had a positive cash flow from operations.
SDGR had negative earnings in 4 of the past 5 years.
SDGR had negative operating cash flow in 4 of the past 5 years.
SDGR Yearly Net Income VS EBIT VS OCF VS FCFSDGR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M -200M

1.2 Ratios

With a Return On Assets value of -25.87%, SDGR is not doing good in the industry: 63.89% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -51.46%, SDGR is in line with its industry, outperforming 44.44% of the companies in the same industry.
Industry RankSector Rank
ROA -25.87%
ROE -51.46%
ROIC N/A
ROA(3y)-13.11%
ROA(5y)-11.18%
ROE(3y)-23.43%
ROE(5y)-18.45%
ROIC(3y)N/A
ROIC(5y)N/A
SDGR Yearly ROA, ROE, ROICSDGR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40

1.3 Margins

The Gross Margin of SDGR (62.61%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of SDGR has grown nicely.
SDGR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 62.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.19%
GM growth 5Y2.08%
SDGR Yearly Profit, Operating, Gross MarginsSDGR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

7

2. Health

2.1 Basic Checks

SDGR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SDGR has been increased compared to 1 year ago.
The number of shares outstanding for SDGR has been increased compared to 5 years ago.
SDGR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SDGR Yearly Shares OutstandingSDGR Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
SDGR Yearly Total Debt VS Total AssetsSDGR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

SDGR has an Altman-Z score of 1.40. This is a bad value and indicates that SDGR is not financially healthy and even has some risk of bankruptcy.
SDGR has a better Altman-Z score (1.40) than 61.11% of its industry peers.
SDGR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.4
ROIC/WACCN/A
WACC10.11%
SDGR Yearly LT Debt VS Equity VS FCFSDGR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

SDGR has a Current Ratio of 3.45. This indicates that SDGR is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 3.45, SDGR is doing good in the industry, outperforming 77.78% of the companies in the same industry.
SDGR has a Quick Ratio of 3.45. This indicates that SDGR is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of SDGR (3.45) is better than 77.78% of its industry peers.
Industry RankSector Rank
Current Ratio 3.45
Quick Ratio 3.45
SDGR Yearly Current Assets VS Current LiabilitesSDGR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

6

3. Growth

3.1 Past

SDGR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -33.50%.
SDGR shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.29%.
The Revenue has been growing by 19.41% on average over the past years. This is quite good.
EPS 1Y (TTM)-33.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7.89%
Revenue 1Y (TTM)22.29%
Revenue growth 3Y14.6%
Revenue growth 5Y19.41%
Sales Q2Q%62.72%

3.2 Future

The Earnings Per Share is expected to grow by 13.50% on average over the next years. This is quite good.
The Revenue is expected to grow by 21.46% on average over the next years. This is a very strong growth
EPS Next Y-4.56%
EPS Next 2Y8.61%
EPS Next 3Y13.5%
EPS Next 5YN/A
Revenue Next Year25.2%
Revenue Next 2Y23.68%
Revenue Next 3Y21.1%
Revenue Next 5Y21.46%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
SDGR Yearly Revenue VS EstimatesSDGR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
SDGR Yearly EPS VS EstimatesSDGR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -1 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SDGR. In the last year negative earnings were reported.
Also next year SDGR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SDGR Price Earnings VS Forward Price EarningsSDGR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

61.11% of the companies in the same industry are more expensive than SDGR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 68.37
EV/EBITDA N/A
SDGR Per share dataSDGR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

SDGR's earnings are expected to grow with 13.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.61%
EPS Next 3Y13.5%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SDGR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SCHRODINGER INC

NASDAQ:SDGR (7/1/2025, 3:22:03 PM)

20.645

+0.52 (+2.61%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)07-29 2025-07-29/amc
Inst Owners101.6%
Inst Owner Change4.04%
Ins Owners2.58%
Ins Owner Change2.37%
Market Cap1.51B
Analysts82.67
Price Target32.41 (56.99%)
Short Float %16.76%
Short Ratio8.74
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-18.29%
Min EPS beat(2)-28.59%
Max EPS beat(2)-7.98%
EPS beat(4)2
Avg EPS beat(4)-1.81%
Min EPS beat(4)-28.59%
Max EPS beat(4)14.87%
EPS beat(8)4
Avg EPS beat(8)10.08%
EPS beat(12)7
Avg EPS beat(12)12.43%
EPS beat(16)8
Avg EPS beat(16)5.79%
Revenue beat(2)2
Avg Revenue beat(2)5.45%
Min Revenue beat(2)4.07%
Max Revenue beat(2)6.83%
Revenue beat(4)3
Avg Revenue beat(4)3.53%
Min Revenue beat(4)-14.72%
Max Revenue beat(4)17.94%
Revenue beat(8)4
Avg Revenue beat(8)-0.88%
Revenue beat(12)7
Avg Revenue beat(12)2.67%
Revenue beat(16)9
Avg Revenue beat(16)5.22%
PT rev (1m)-0.69%
PT rev (3m)-0.98%
EPS NQ rev (1m)3.13%
EPS NQ rev (3m)-4.81%
EPS NY rev (1m)1.68%
EPS NY rev (3m)-3.88%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.29%
Revenue NY rev (1m)-0.22%
Revenue NY rev (3m)-3.3%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.57
P/FCF 68.37
P/OCF 58.33
P/B 4.06
P/tB 4.11
EV/EBITDA N/A
EPS(TTM)-2.63
EYN/A
EPS(NY)-2.11
Fwd EYN/A
FCF(TTM)0.3
FCFY1.46%
OCF(TTM)0.35
OCFY1.71%
SpS3.14
BVpS5.09
TBVpS5.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.87%
ROE -51.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 62.61%
FCFM 9.61%
ROA(3y)-13.11%
ROA(5y)-11.18%
ROE(3y)-23.43%
ROE(5y)-18.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.19%
GM growth 5Y2.08%
F-Score5
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 60.39%
Cap/Sales 1.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.45
Quick Ratio 3.45
Altman-Z 1.4
F-Score5
WACC10.11%
ROIC/WACCN/A
Cap/Depr(3y)181.56%
Cap/Depr(5y)173.13%
Cap/Sales(3y)4.71%
Cap/Sales(5y)4.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7.89%
EPS Next Y-4.56%
EPS Next 2Y8.61%
EPS Next 3Y13.5%
EPS Next 5YN/A
Revenue 1Y (TTM)22.29%
Revenue growth 3Y14.6%
Revenue growth 5Y19.41%
Sales Q2Q%62.72%
Revenue Next Year25.2%
Revenue Next 2Y23.68%
Revenue Next 3Y21.1%
Revenue Next 5Y21.46%
EBIT growth 1Y10.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year16.46%
EBIT Next 3Y19.59%
EBIT Next 5YN/A
FCF growth 1Y118.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y123.39%
OCF growth 3YN/A
OCF growth 5YN/A